Swiss Helvetia Fund

Summary

Swiss Helvetia Fund is the famous VC, which was founded in 1986. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the New York.

Besides them, we counted 2 critical employees of this fund in our database.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Mineral, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Kuros Biosciences, Synosia Therapeutics.

The standard case for the fund is to invest in rounds with 5 partakers. Despite the Swiss Helvetia Fund, startups are often financed by Versant Ventures, VI Partners AG, VINCI CAPITAL. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Investor Growth Capital Limited, Aravis Ventures. In the next rounds fund is usually obtained by Versant Ventures, UCB Pharma, Novo Holdings.

Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2015. Comparing to the other companies, this Swiss Helvetia Fund performs on 21 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.